Questions and answers on workup diagnosis and risk stratification: a companion document of the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Olivier Barthélémy; Alexander Jobs; Emanuele Meliga; Christian Mueller; Frans H Rutten; George C M Siontis; Holger Thiele; Jean-Philippe Collet; ESC Scientific Document Group

doi:10.1093/eurheartj/ehaa602

Questions and answers on workup diagnosis and risk stratification: a companion document of the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Eur Heart J. 2021 Apr 7;42(14):1379-1386. doi: 10.1093/eurheartj/ehaa602.

Authors

Olivier Barthélémy¹, Alexander Jobs², Emanuele Meliga³, Christian Mueller⁴, Frans H Rutten⁵, George C M Siontis⁶, Holger Thiele, Jean-Philippe Collet; ESC Scientific Document Group

Collaborators

ESC Scientific Document Group:
Adnan Kastrati, Mamas A Mamas, Stephan Windecker

Affiliations

¹ Sorbonne Université, ACTION Study Group, Institut de Cardiologie, Hôpital Pitié-Salpêtrière (Assistance Publique- Hôpitaux de Paris) (AP-HP), Paris, France.
² Department of Internal Medicine/Cardiology, Heart Center Leipzig at University of Leipzig, Leipzig, Germany.
³ Interventional Cardiology, AO Mauriziano Umberto I, Turin, Italy.
⁴ Cardiovascular Research Institute Basel (CRIB) and Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland.
⁵ General Practice, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
⁶ Department of Cardiology, University Hospital of Bern, Inselspital, Bern, Switzerland.

No abstract available

Keywords: Acute cardiac care; Acute coronary syndrome; Angioplasty; Anticoagulation; Antiplatelet; Apixaban; Aspirin; Atherothrombosis; Betablockers; Bivalirudin; Bleedings; Bypass surgery; Cangrelor; Chest pain unit; Clinical cases; Clopidogrel; Dabigatran; Diabetes; Dual antithrombotic therapy; Early invasive strategy; Edoxaban; Enoxaparin; European Society of Cardiology; Fondaparinux; Glycoprotein IIb/IIIa inhibitors; Guidelines; Heparin; High-sensitivity troponin; MINOCA; Myocardial infarction; Myocardial ischaemia; Nitrates; Non-ST-elevation myocardial infarction; Platelet inhibition; Prasugrel; Recommendations; Revascularisation; Rhythm monitoring; Rivaroxaban; Stent; Ticagrelor; Triple therapy; Unstable angina.

MeSH terms

Acute Coronary Syndrome / diagnosis*
Humans
Practice Guidelines as Topic
Risk Assessment